Is Idexx (IDXX) a Solid Growth Stock? 3 Reasons to Think "Yes"

Idexx Laboratories (IDXX) is identified as a compelling growth stock, receiving a Zacks Growth Score of A and a Zacks Rank #2. This positive outlook is underpinned by strong financial indicators, including a projected 16.6% EPS growth for the current year, significantly exceeding the industry average of 12.4%, and a current year-over-year cash flow growth of 6% against an industry average of -2.6%. Furthermore, the company has seen positive earnings estimate revisions, with current-year estimates increasing by 3.8% over the past month, positioning IDXX for potential outperformance.

Analysis

Idexx Laboratories (IDXX) presents a compelling case as a growth investment, supported by strong quantitative metrics and positive analyst sentiment. The company is projected to deliver 16.6% EPS growth this year, a figure that significantly outpaces the animal health industry's average expectation of 12.4%. This earnings momentum is complemented by robust cash flow generation; IDXX's year-over-year cash flow has grown by 6%, which stands in stark contrast to the industry's average contraction of -2.6%. This strong current performance is also consistent with its historical trend, where annualized cash flow growth was 14.6% over the last 3-5 years, more than double the industry average of 6.3%. Further bolstering the bull case is the upward trend in earnings estimates, with the Zacks Consensus Estimate for the current year having increased by 3.8% in the past month. According to the source, this combination of a 'Growth Score of A' and a 'Zacks Rank #2 (Buy)' has historically been correlated with market outperformance.

Key Decisions for Investors

• Growth-oriented investors should view IDXX favorably, as the combination of superior earnings growth projections, strong cash flow relative to its industry, and positive earnings estimate revisions signals potential for stock price appreciation.
• It is crucial to monitor upcoming earnings releases to confirm that the company maintains its double-digit EPS growth trajectory and that cash flow generation remains strong, as these are the core pillars of the current investment thesis.
• Despite the optimistic outlook, investors should factor in the inherently higher volatility and risk associated with growth stocks and manage position sizes accordingly.